In 2000, DLJMB acquired Focus Diagnostics, a scientifically driven infectious disease diagnostics company that has consistently been among the first to develop diagnostics for new infectious disease agents such as West Nile Virus and SARS. The fund exited the investment via a strategic sale in 2006 to Quest Diagnostics, the nation’s leading provider of diagnostic testing, information and services and Eurofins Scientific, a global leader in bio-analysis.
Location: United States, Virginia, Herndon
Investors 2
| Date | Name | Website |
| - | Avista Cap... | avistacap.... |
| - | New Leaf V... | nlvpartner... |
Mentions in press and media 10
| Date | Title | Description |
| 10.09.2012 | Avista Capital Partners Appoints Brian A. Markison Healthcare Industry Executive | New York, NY, Sept. 10, 2012 – Avista Capital Partners today announced that Brian A. Markison has joined the firm as a healthcare Industry Executive. Mr. Markison has more than 30 years of experience in the pharmaceuticals sector, most rece... |
| 20.01.2012 | Multiple sclerosis: BIIB’s Tysabri gets FDA O.K. on test, label change | The FDA also granted Weston, Massachusetts-based Biogen Iden a label change for Tysabri that updates the risk factors of developing PML for MS and Crohn’s disease patients. RBC Capital Markets analyst Michael Yee told Bloomberg News that th... |
| 17.12.2007 | Avista Capital Partners Agrees To Acquire Bristol-Myers Squibb Medical Imaging For Approximately $525 Million | New York, NY, December 17, 2007 – Bristol-Myers Squibb Company (NYSE: BMY) and Avista Capital Partners, a leading private equity firm, announced today the parties have signed a definitive agreement for Avista to acquire Bristol-Myers Squibb... |
| 13.12.2007 | Boston Scientific Agrees to Sell Fluid Management And Venous Access Business To Avista Capital Partners for $425 Million | Natick, MA and New York, NY December 13, 2007 – Boston Scientific Corporation (NYSE: BSX) and Avista Capital Partners, a leading private equity firm, today jointly announced the signing of a definitive agreement under which Avista will acqu... |
| 17.10.2007 | Avista Capital Partners bolsters healthcare practice with appointments of Charles Harwood and Ron Sparks | New York, NY, October 17, 2007 – Avista Capital Partners, a leading private equity firm, today announced that it has hired Charles C. Harwood, Jr., a proven operator in the clinical diagnostics and pharmaceutical services industries, and Ro... |
| 12.04.2007 | Avista Capital Partners completes acquisition Of Bioreliance Corporation from Invitrogen Corporation | New York, NY, April 12, 2007 – Avista Capital Partners, a leading private equity firm, announced today it has completed its acquisition of BioReliance Corporation, a business unit of Invitrogen Corporation (NASDAQ: IVGN) for approximately $... |
| 13.02.2007 | Avista Capital Partners agrees to acquire Bioreliance Corporation for approximately $210 million | New York, NY, February 13, 2007 – Avista Capital Partners, a leading private equity firm, announced today it has signed a definitive agreement to acquire BioReliance Corporation, a business unit of Invitrogen Corporation (NASDAQ: IVGN) for ... |
| 19.05.2006 | Quest Diagnostics to Acquire Focus Diagnostics, Inc., A World Leader in Infectious Disease Testing | Lyndhurst, NJ, and Herndon, VA, May 19, 2006 – PRNewswire-FirstCall — Quest Diagnostics Incorporated , the nation’s leading provider of diagnostic testing, information and services, has agreed to acquire Focus Diagnostics, Inc., the premier... |
| - | Multiple sclerosis: BIIB’s Tysabri gets FDA O.K. on test, label change | Multiple sclerosis patients using Biogen Idec (NASDAQ:BIIB) drug Tysabri now have access to the first test that can help determine their risk for developing a rare but potentially fatal brain infection that affects some patients using the d... |
| - | Avista Capital Partners Appoints Hakan Bjorklund As Healthcare Operating Executive | Departing Nycomed CEO Bolsters Leading Private Equity Healthcare Practice New York, NY, October 3, 2011 – Avista Capital Partners, a leading private equity firm, today announced that it has hired Håkan Björklund, the departing Chief Execut... |